Business Description
Vyome Holdings Inc
NAICS : 541715
SIC : 2834
ISIN : US92943X1046
Total Employee Number:
18Description
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 382.44 | |||||
Equity-to-Asset | 0.66 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -11.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 29 | |||||
3-Year EBITDA Growth Rate | -191.4 | |||||
3-Year EPS without NRI Growth Rate | -78.9 | |||||
3-Year FCF Growth Rate | -198.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 38.36 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 20 | |||||
9-Day RSI | 30.67 | |||||
14-Day RSI | 36.97 | |||||
3-1 Month Momentum % | 2.86 | |||||
6-1 Month Momentum % | -14.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.27 | |||||
Quick Ratio | 4.27 | |||||
Cash Ratio | 4.1 | |||||
Days Sales Outstanding | 29.63 | |||||
Days Payable | 4271.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | -20.67 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.25 | |||||
Operating Margin % | -2388.31 | |||||
Net Margin % | -7098.05 | |||||
EBITDA Margin % | -7187.01 | |||||
FCF Margin % | -3234.42 | |||||
OCF Margin % | -3234.42 | |||||
ROE % | -650.46 | |||||
ROA % | -172.46 | |||||
ROIC % | -155.6 | |||||
3-Year ROIIC % | 70.21 | |||||
ROC (Joel Greenblatt) % | -13471.12 | |||||
ROCE % | -412.2 | |||||
Moat Score | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 60.3 | |||||
PB Ratio | 2.07 | |||||
Price-to-Tangible-Book | 2.16 | |||||
EV-to-EBIT | -0.59 | |||||
EV-to-EBITDA | -0.59 | |||||
EV-to-Revenue | 42.15 | |||||
EV-to-Forward-Revenue | 31.29 | |||||
EV-to-FCF | -1.3 | |||||
| Price-to-Net-Current-Asset-Value | 2.43 | |||||
| Price-to-Net-Cash | 2.62 | |||||
Earnings Yield (Greenblatt) % | -169.49 | |||||
FCF Yield % | -35.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HIND
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vyome Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.154 | ||
| EPS (TTM) ($) | -3.505 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 36.97 | ||
| 14-Day ATR ($) | 0.10174 | ||
| 20-Day SMA ($) | 2.172545 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 1.75 - 16 | ||
| Shares Outstanding (Mil) | 7.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vyome Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vyome Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 124 days | ||
| Second quarter earnings results for 2026 | 2026-08-31 | In 33 days | ||
| First quarter earnings conference call for 2026 | 2026-06-03 11:00 | 2.30 (+2.68%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 1.97 (-2.96%) | ||
| General meeting for 2026 | 2026-04-24 12:00 | 2.26 (+1.80%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-30 11:00 | 2.13 (+0.47%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-30 | 2.13 (+0.47%) | ||
| Annual report for 2025 | 2026-03-18 | 2.12 (-3.64%) |
Show
Entries
Vyome Holdings Inc Frequently Asked Questions
What is Vyome Holdings Inc(HIND)'s stock price today?
The current price of HIND is $1.99. The 52 week high of HIND is $16.00 and 52 week low is $1.75.
When is next earnings date of Vyome Holdings Inc(HIND)?
The next earnings date of Vyome Holdings Inc(HIND) is 2026-08-31 Est..
Does Vyome Holdings Inc(HIND) pay dividends? If so, how much?
Vyome Holdings Inc(HIND) does not pay dividend.
Guru Commentaries on NAS:HIND
No articles.
Press Release
Articles on Vyome Holdings Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers